Fresenius reported €10.02B in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Akzo Nobel AKZA:NA € 2853M 328M
Alcon AG ALC:SW 2.12B 71.99M
AstraZeneca AZN:LN 884686.86M 17406.7M
BASF BAS:GR € 22975M 108M
Bayer BAYN:GR € 12819M 1820M
Beiersdorf BEI:GR 2.22B 330M
Davita Healthcare Partners DVA:US $ 2926.76M 109.2M
E.ON EOAN:GR 29.51B 236M
Essilor EI:FP 11.99B 942M
Fresenius FRE:GR € 10018M 298M
Fresenius Medical Care FME:GR € 4757M 208.63M
Fresenius Medical Care FMS:US $ 4757M 208.63M
Getinge GETIB:SS SK 6670M 488M
Givaudan GIVN:VX 3.65B 341M
GlaxoSmithKline GSK:LN 692900M 26100M
GN Store Nord GN:DC DK 4857M 998M
Hikma Pharmaceutical HIK:LN 99.63B 806.61M
Lonza Group LONN:SW 2.98B 115M
Merck MRK:GR € 5568M 370M
Novartis NOVN:VX SF 13085M 271M
Philips PHIA:NA € 4177M 259M
Roche Holding ROG:VX 16.44B 474M
RWE RWE:GR € 8245M 302M
William Demant Holding WDH:DC 9.5B 121M